Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.

http://www.wikidata.org/entity/Q35795672

about

Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex What have novel imaging techniques revealed about metabolism in the aging brain?Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.Estrogen: a master regulator of bioenergetic systems in the brain and body New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Is Alzheimer's disease a systemic disease?Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease.Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?Brain aging, Alzheimer's disease, and mitochondria.Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.Maternal family history is associated with Alzheimer's disease biomarkers Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood.Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.Neuroketotherapeutics: A modern review of a century-old therapy.Mitochondria, Cybrids, Aging, and Alzheimer's Disease.The Bioenergetic Health Index is a sensitive measure of oxidative stress in human monocytes.Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer's disease neurodegeneration.Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism.Psychological Stress and Mitochondria: A Conceptual Framework.Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice.

P2860

Q26830740-28869605-24EC-4F20-B8E1-32C05B959B49 Q26865358-F2337007-C8CE-4F39-9A3C-E4372C5490D7 Q28077056-904B9151-F22B-4672-A029-858AECF798C4 Q30850844-8D3A4490-8945-43A1-9620-9CB52B17B3B5 Q33585950-8E9950FC-9377-4560-B3E0-8630A5420D76 Q33603263-78A59214-5560-47A6-B6AF-4BA6F57E65BA Q33607473-36F898A1-F7ED-4603-9690-175E6D6B5924 Q33623924-5B7CC476-AD89-47FD-8829-B3C3F1B6E502 Q33783000-3ADE28A3-6088-4FAF-BC63-264B98A5C7DD Q34019193-F77D0C96-60D9-4D41-A892-AE11C03B7A10 Q34359099-3A43D710-1389-4687-988B-2E73F731B2BD Q34500658-56C0F7B0-799D-4ADD-82A7-6132CABD9CE6 Q35533354-280D8FB3-DD5F-4275-9BC5-656EEE3E841B Q35737647-812C088F-1BD2-42F1-87E7-B77EFBF43240 Q35898628-0EAF6C49-8D0E-4AFD-8CC5-89F0889B6E0E Q35916588-A2AEA1AA-2121-493E-B039-761569D5B232 Q36437623-838FCA80-79C6-4421-954E-7236A8265A8A Q36717013-56DCCCC7-2AE7-43CD-B9A7-B06DDC643E9B Q36906968-0C6A1C4E-B776-4191-A55F-B767C7F0C5DD Q37436607-A01106F6-0F59-4BBD-B5BC-E5D2CBD1CE21 Q37541024-D724A137-B248-4763-9333-1C1B371E15D5 Q37628346-042808D7-84EB-49D3-BEB3-0BCF367B96CD Q37656554-92160EB4-E371-4C61-B1D0-E3B3788A3966 Q37675866-60759570-8123-4FA1-96E8-40500B374E56 Q38570535-6296D947-24CE-4961-B372-5EF5445D69F3 Q38745984-8F3249D0-5F63-4558-A4B3-2AC3D44716A5 Q38932850-19253022-36C0-4492-BF36-7BC31DB8883D Q40126571-056DBCF2-97A9-41F9-96D4-DFAF9B354A92 Q42103602-D6EC5F48-5BB5-43EA-86B7-1DA0CA5F3F1D Q42690171-70B73FB2-0750-4904-9166-84AEE854B24A Q46331471-BBB20EDC-7C99-4A4C-AFEF-C3C582209AEE Q47550262-1BECF2C4-D3E1-43B8-A852-DB07D3C8F5CB Q47784287-EE7B535A-6FB6-4B76-B481-2193643E21EB Q47874796-FFB51C20-A853-430D-929A-AF191759E519 Q50592925-0EEDD781-FA60-487D-995D-82AFB74B3FB5 Q52565458-48DF34DD-155E-4FC8-A397-72EF709CCED4

P2860

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.

http://www.wikidata.org/entity/Q35795672

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@ast

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@en

type

label

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@ast

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@en

prefLabel

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@ast

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@en

P1433

Q35795672-5DAB8BA5-B4C9-4914-B32A-FD86E6DB24A7

P1476

Q35795672-00ED9F0B-7D1E-4E5F-A2FD-0C22DEBB51C7

P2093

Q35795672-29EB6F68-FC5A-4AB2-96B5-BA4E28868A18

Q35795672-5A68B696-6DC8-4696-BB9D-00832348D3BC

Q35795672-6D6A23F0-28BD-4B8B-942D-A467EBCE7085

Q35795672-786CDA4E-491B-4794-95F8-A3F5BDCB4BB1

Q35795672-83FFC2B9-2233-4C0F-8BBC-F949EF27AE10

Q35795672-DBE1FD03-5E40-4B9B-B66D-EA68EBD8A305

Q35795672-EBB82EAD-FDA1-4443-8A62-F08CADE26576

P2860

Q35795672-0A7125C3-A758-4232-BB56-FE8ED1000DE5

Q35795672-107E396D-2BAE-4A68-BFB9-337063E47EA4

Q35795672-122A4127-734E-433B-9752-75BB7B2A8955

Q35795672-17FB481F-2269-459E-AFC3-4A91F0581E7E

Q35795672-19AD95C3-7DD5-48B0-9200-4C2F2AB215BB

Q35795672-1B39CC6A-A41B-49F9-AFD5-6E80EA638471

Q35795672-1C032C51-8201-4BD0-906A-4941087EA4AF

Q35795672-1CFE5A14-BFCF-4426-8AF5-898D672C200F

Q35795672-24689BA3-7840-4FE3-9A3A-2005B2E8C6F3

Q35795672-275234B3-CD28-4DBD-AC5E-AE63C0ACB880

P304

Q35795672-8C2DF578-B0E0-4191-8DC8-BF4B00C8D770

P31

Q35795672-1D09A21C-0E9C-4A8E-8F30-A3666270F706

P356

Q35795672-F9B34237-C6C4-430F-9906-6CD4AD1D53A6

P433

Q35795672-4FBB988A-575F-46C1-9FEB-ABE36B1FE15F

P478

Q35795672-43F3DD59-427B-415C-880E-ADEA82333369

P50

Q35795672-9552940C-DBCF-408C-B838-E7F4FFCA8A2A

P577

Q35795672-B2B7B776-0C53-49B1-AA4C-3713B8BC4247

P698

Q35795672-8008859D-BE8B-4EA3-95DA-7F6BA63923DB

P921

Q35795672-E95DC9C4-8790-48F2-96B3-7AB75ECF63C6

P932

Q35795672-DBC3724A-1377-4EA6-B080-09785901C29D

P356

JAD-2011-110866

P1433

Journal of Alzheimer's Disease

P1476

Reduced mitochondria cytochrom ...... hers with Alzheimer's disease.

@en

P2093

Elizabeth Javier

http://www.w3.org/2001/XMLSchema#string

Jianghua Lu

http://www.w3.org/2001/XMLSchema#string

John Murray

http://www.w3.org/2001/XMLSchema#string

Lezi E

http://www.w3.org/2001/XMLSchema#string

Lisa Mosconi

http://www.w3.org/2001/XMLSchema#string

Pauline McHugh

http://www.w3.org/2001/XMLSchema#string

Russell H Swerdlow

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.

Mitochondria in Alzheimer's disease.

Polymorphic variation in cytochrome oxidase subunit genes.

Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.

Cybrids in Alzheimer's disease: a cellular model of the disease?

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.

Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.

P304

483-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2011-110866

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21841246

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3291954

http://www.w3.org/2001/XMLSchema#string